Genetic damage caused by methylazoxymethanol acetate, the aglycone of cycasin. Analysis of sister-chromatid exchange frequency under in vivo conditions and in cell cultures.

Abstract:

:To extend the information on the mutagenic effect of methylazoxymethanol (MAM) acetate, which has been established as a potent carcinogen, the frequency of sister-chromatid exchange (SCE) was determined in bone marrow cells of Sprague Dawley rats and in cultured rat lymphocytes. To get differentially stained chromatids under in vivo conditions, the rats received 5-bromodeoxyuridine adsorbed on activated charcoal intraperitoneally. Chromosomes were stained with fluorescence plus Giemsa. In this study a significant increase of SCE frequency after the application of various concentrations of MAM acetate could be observed both in vivo and in vivo.

journal_name

Oncology

journal_title

Oncology

authors

Gloser H

doi

10.1159/000225615

subject

Has Abstract

pub_date

1982-01-01 00:00:00

pages

101-3

issue

2

eissn

0030-2414

issn

1423-0232

journal_volume

39

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • Heritable colonic cancer syndromes: induction of anchorage-independence in dermal cultures derived from patients with adenomatosis of the colon and rectum.

    abstract::After exposure to the mutagen, ethylmethanesulfonate (EMS), or the carcinogen, urethane (UR), anchorage independence was observed in cultures derived from normal skin biopsies from patients with the heritable cancer syndrome, adenomatosis of the colon and rectum (ACR). Such colonies from methylcellulose suspension cul...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225478

    authors: Danes BS

    更新日期:1980-01-01 00:00:00

  • A phase II trial of vindesine in hepatocellular cancer.

    abstract::Sixteen patients with histologically confirmed inoperable hepatocellular carcinoma were treated with vindesine 3 mg/m2 i.v. weekly. Anemia, leukopenia and neuritis were documented but no severe or life-threatening toxicity was seen. There were no objective responses among the 14 evaluable patients. Eight had a no chan...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227434

    authors: Falkson G,Burger W

    更新日期:1995-01-01 00:00:00

  • Differential growth characteristics of low and high metastatic variant RAW117 murine lymphosarcoma cells.

    abstract::The Abelson-virus-induced murine lymphosarcoma cell line RAW117-P and its in vivo selected highly malignant and metastatic variant RAW117-H10 have been studied for their growth in vivo, in vitro and in semi-solid agar. The highly malignant metastatic variant RAW117-H10 cells killed syngeneic Balb/c mice rapidly and fo...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226473

    authors: Joshi SS,Sharp JG,Brunson KW

    更新日期:1987-01-01 00:00:00

  • Sinophobic growth in oestrogen receptor-negative metastatic breast cancer.

    abstract::The mode of growth of tumour cells from primary breast carcinoma in the axillary nodes is shown to be related to the oestrogen receptor (ER) status of the primary tumour. ER-positive primaries are described as tending to show sinophilic growth, the tumour cells spreading along the nodal sinuses; while the ER-negative ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225735

    authors: Hartveit F,Thorsen T,Tangen M,Maehle BO,Thoresen S,Halvorsen JF

    更新日期:1983-01-01 00:00:00

  • Capecitabine and mitomycin C is an effective combination for anthracycline- and taxane-resistant metastatic breast cancer.

    abstract::Capecitabine is converted to 5-fluorouracil by thymidine phosphorylase, and mitomycin C is capable of upregulating the expression of thymidine phosphorylase suggesting a synergistic effect. Fifty-three patients (median age 62 years) with anthracycline- and taxane-resistant, metastatic breast cancer received mitomycin ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000096250

    authors: Massacesi C,La Cesa A,Marcucci F,Pilone A,Rocchi MB,Zepponi L,Santini D,Tonini G,Burattini L

    更新日期:2006-01-01 00:00:00

  • Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin.

    abstract:OBJECTIVES:Low body mass index (BMI) and/or low lean body mass have been shown to be risk factors for chemotherapy-related toxicities in a number of different cancers. However, no data are available regarding the role of BMI as a risk factor for developing toxicities related to the novel anticancer agent, trabectedin, ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000487266

    authors: Vincenzi B,Badalamenti G,Armento G,Silletta M,Spalato Ceruso M,Catania G,Napolitano A,Maltese G,Valeri S,Incorvaia L,Santini D,Tonini G

    更新日期:2018-01-01 00:00:00

  • Outcome of patients with melanoma and histologically negative sentinel lymph nodes: one institution's experience.

    abstract:BACKGROUND:Since its introduction by Morton in 1992, sentinel lymph node (SLN) biopsy has become a standard procedure in the staging and treatment of primary melanoma and clinically negative regional lymph nodes. The primary aims of this procedure are to ascertain the individual lymphatic drainage patterns of primary t...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000136795

    authors: De Giorgi V,Leporatti G,Massi D,Lo Russo G,Sestini S,Dini M,Lotti T

    更新日期:2007-01-01 00:00:00

  • Docetaxel in patients with anthracycline-resistant advanced breast cancer.

    abstract:OBJECTIVE:To better determine docetaxel activity in patients with well-defined anthracycline-resistant breast cancer. METHODS:From October 1996, we carried out a phase II trial in 69 heavily pretreated patients with advanced breast cancer with docetaxel 100 mg/m(2) by a 1-hour infusion on day 1, with cycles repeated e...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000055298

    authors: Vici P,Belli F,Di Lauro L,Amodio A,Conti F,Foggi P,Gionfra T,Morelli MF,Botti C,Ferraironi A,Lopez M

    更新日期:2001-01-01 00:00:00

  • Immunologic and immunohistochemical studies on chronic lymphocytic thyroiditis with or without thyroid lymphoma.

    abstract::The local immunologic phenomena in the thyroid gland of 16 patients with chronic lymphocytic thyroiditis (CLTH) were investigated; 5 of these cases were associated with thyroid non-Hodgkin's lymphomas (NHL). All patients were admitted because of struma, growing slowly in patients with CLTH alone and rapidly in those w...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226897

    authors: Aozasa K,Tajima K,Tominaga N,Katagiri S,Yonezawa T,Matsuzuka F,Kuma K,Sawada M

    更新日期:1991-01-01 00:00:00

  • HER2 as a prognostic factor in breast cancer.

    abstract::HER2 amplification/overexpression is a marker of poor prognosis in breast cancer. The prognostic impact of HER2 positivity is lower in node-negative compared with node-positive women. The only significant, independent prognostic factors in breast cancer are node status, HER2 status and menopausal status. HER2-positive...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000055404

    authors: Ménard S,Fortis S,Castiglioni F,Agresti R,Balsari A

    更新日期:2001-01-01 00:00:00

  • Unexpectedly low incorporation of isotopic acetate into lipids of Ehrlich ascites tumor cells cultured in lipid-poor medium.

    abstract::The present communication reports data on the lipid biosynthesis of Ehrlich ascites tumor cells grown in culture media supplemented with modified sera. Whereas the metabolisms of [14C]pyruvate and [14C]mevalonate are identical in all media tested, the incorporation of [14C] acetate is higher in medium with dialyzed se...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225321

    authors: Löffler M,Schneider F

    更新日期:1979-01-01 00:00:00

  • Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer.

    abstract:OBJECTIVE:Ovarian cancer is the most lethal gynecological malignancy, but information relevant to prognosis and outcomes remain unknown. Here, we used statistical methods to focus specifically on interactions between candidate prognostic variables. METHODS AND RESULTS:Univariate, multivariate, and elastic net modeling...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000442710

    authors: Jatoi A,Vierkant RA,Hawthorne KM,Block MS,Ramus SJ,Larson NB,Fridley BL,Goode EL

    更新日期:2016-01-01 00:00:00

  • Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with prostate cancer - EORTC QLQ-PR25.

    abstract:OBJECTIVE:We evaluated the psychometric properties of the Korean version of the European Organization for Research and Treatment of Cancer QLQ-PR25 when applied to Korean prostate cancer (PC) patients. METHODS:A total of 172 patients who underwent curative radical prostatectomy (RP) with or without adjuvant androgen d...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000355689

    authors: Park J,Shin DW,Yun SJ,Park SW,Jeon SS,Kwak C,Kwon TG,Kim HJ,Ahn H

    更新日期:2013-01-01 00:00:00

  • Matched-pair analysis in patients with advanced oropharyngeal cancer: surgery versus concurrent chemoradiotherapy.

    abstract:OBJECTIVE:The current study aimed to compare the therapeutic outcomes of surgery with those of chemoradiation for patients with advanced oropharyngeal cancer (OPC). METHODS:The data for 523 patients with previously untreated OPC were obtained from 12 institutions belonging to the Head and Neck Cancer Study Group in th...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000346908

    authors: Kano S,Homma A,Hayashi R,Kawabata K,Yoshino K,Iwae S,Hasegawa Y,Nibu K,Kato T,Shiga K,Matsuura K,Monden N,Fujii M

    更新日期:2013-01-01 00:00:00

  • T-cell subsets in patients with gastric cancer.

    abstract::Peripheral blood T-cell subsets of 70 patients with untreated gastric cancer and 55 age- and sex-matched normal controls were studied by using monoclonal antibodies and flow cytometry. The number of T cells (Leu 4+ cells) was significantly decreased in stage IV patients. Statistically significant decreases in the numb...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226007

    authors: Watanabe T,Nakauchi H,Kitaoka H,Matsuki K,Okumura K,Nomura K,Takakura K

    更新日期:1985-01-01 00:00:00

  • Prognostic factors and prognostic index for chemonaïve and gemcitabine-refractory patients with advanced pancreatic cancer.

    abstract:BACKGROUND:Gemcitabine monotherapy is the cornerstone of the treatment of patients suffering from advanced pancreatic cancer (PC). For a few years, new chemotherapeutic agents and combinations have been under validation. The use of such treatment makes it necessary to determine factors that could predict survival time....

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000120627

    authors: Maréchal R,Demols A,Gay F,De Maertelaere V,Arvanitaki M,Hendlisz A,Van Laethem JL

    更新日期:2007-01-01 00:00:00

  • Antiemetic study methodology: recommendations for future studies.

    abstract::The methodology of future antiemetic studies will reflect the need to address the problems identified in current studies. New preclinical information on the mechanisms of emesis and antiemetic action will allow more rational clinical study design. Prior to large randomized studies, phase I and II trials should define ...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000227648

    authors: Olver IN

    更新日期:1996-06-01 00:00:00

  • Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?

    abstract:OBJECTIVES:Our aim was to assess FDG-PET/CT as a surrogate biomarker of the pathological complete response in locally advanced rectal cancer treated with neoadjuvant chemoradiation. METHODS:T3-4 and/or N+ rectal cancer patients were treated prospectively with capecitabine-based chemoradiation and total mesorectal exci...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000345601

    authors: Bampo C,Alessi A,Fantini S,Bertarelli G,de Braud F,Bombardieri E,Valvo F,Crippa F,Di Bartolomeo M,Mariani L,Milione M,Biondani P,Avuzzi B,Chiruzzi C,Pietrantonio F

    更新日期:2013-01-01 00:00:00

  • Prospective comparison of sorafenib and sunitinib for second-line treatment of cytokine-refractory kidney cancer patients.

    abstract:OBJECTIVES:It was the aim of this study to investigate the clinical differences between the tyrosine kinase inhibitors (TKIs) sorafenib and sunitinib as second-line treatment for cytokine-refractory kidney cancer patients. METHODS:Twenty consecutive patients received continuous treatment of oral sorafenib at a dose of...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000151369

    authors: Herrmann E,Bierer S,Gerss J,Köpke T,Hertle L,Wülfing C

    更新日期:2008-01-01 00:00:00

  • Assessment of quality of care in an oncology institute using information on patients' satisfaction.

    abstract:OBJECTIVE:To evaluate the feasibility of conducting a patient satisfaction survey in the oncology hospital setting, using a multidimensional patient satisfaction questionnaire to be completed at home. METHODS:Socio-demographic and clinical data were collected for 133 consecutive patients. Patients were asked to comple...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000055362

    authors: Brédart A,Razavi D,Robertson C,Didier F,Scaffidi E,Fonzo D,Autier P,de Haes JC

    更新日期:2001-01-01 00:00:00

  • A newly identified MAGE-3-derived, HLA-A24-restricted peptide is naturally processed and presented as a CTL epitope on MAGE-3-expressing gastrointestinal cancer cells.

    abstract:PURPOSE:In order to broaden the possibility for anti-MAGE-3 immune targeting, it is important to identify HLA-A24-restricted epitopes derived from MAGE-3, since HLA-A24 is one of the most common alleles in Japanese and Asian people. In the present study, we defined a new MAGE-3 derived, HLA-A24-binding peptide presente...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000091185

    authors: Miyagawa N,Kono K,Mimura K,Omata H,Sugai H,Fujii H

    更新日期:2006-01-01 00:00:00

  • Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.

    abstract:OBJECTIVE:The present study evaluated the clinical relevance of an integrative preoperative assessment of inflammation-, nutrition-, and muscle-based markers for patients with muscle-invasive bladder cancer (MIBC) undergoing curative radical cystectomy (RC). METHODS:The analysis enrolled 117 patients and the variables...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000477405

    authors: Miyake M,Morizawa Y,Hori S,Marugami N,Iida K,Ohnishi K,Gotoh D,Tatsumi Y,Nakai Y,Inoue T,Anai S,Torimoto K,Aoki K,Tanaka N,Shimada K,Konishi N,Fujimoto K

    更新日期:2017-01-01 00:00:00

  • Outcome disparities among ethnic subgroups of Waldenström's macroglobulinemia: a population-based study.

    abstract:BACKGROUND:Ethnic disparities in cancers are associated with variability in clinical outcomes. We present a Surveillance Epidemiology and End RESULTS (SEER)-based outcome analysis of multiethnic Waldenström's macroglobulinemia (WM) patients. METHODS:Adult WM patients diagnosed in 1992 or later (n = 3,175) were analyze...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000360992

    authors: Ailawadhi S,Kardosh A,Yang D,Cozen W,Patel G,Alamgir MA,Chanan-Khan AA

    更新日期:2014-01-01 00:00:00

  • A comparison of ondansetron with alizapride plus methylprednisolone in the control of cisplatin-induced emesis. The French Pneumology Group for the Ondansetron Study.

    abstract::This randomised, single-blind, parallel-group study was carried out in 48 French pneumology centres to compare the anti-emetic efficacy of ondansetron and an alizapride plus methylprednisolone (ALI/MPS) combination in patients receiving high-dose cisplatin. A total of 220 patients were recruited of whom 209 were evalu...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000227061

    authors: Depierre A,Lebeau B,d'Allens H

    更新日期:1992-01-01 00:00:00

  • Low expression of transforming growth factor beta-1 in cancer tissue predicts a poor prognosis for patients with stage III rectal cancers.

    abstract:OBJECTIVE:Transforming growth factor beta (TGF-β) plays an important role in tumorigenesis and metastasis. It works as a tumor suppressor in the normal colon, but acts as a cancer promoter during the late stages of colorectal carcinogenesis. High expression of TGF-β is known to be associated with advanced stages, tumor...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000358064

    authors: Chun HK,Jung KU,Choi YL,Hong HK,Kim SH,Yun SH,Kim HC,Lee WY,Cho YB

    更新日期:2014-01-01 00:00:00

  • Modern Information Technology for Cancer Research: What's in IT for Me? An Overview of Technologies and Approaches.

    abstract::Information technology (IT) can enhance or change many scenarios in cancer research for the better. In this paper, we introduce several examples, starting with clinical data reuse and collaboration including data sharing in research networks. Key challenges are semantic interoperability and data access (including data...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000493638

    authors: Ahlbrandt J,Lablans M,Glocker K,Stahl-Toyota S,Maier-Hein K,Maier-Hein L,Ückert F

    更新日期:2020-01-01 00:00:00

  • Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.

    abstract:OBJECTIVE:To report the outcomes of surgical resection of borderline resectable (BL) and locally advanced (LA) 'unresectable' pancreatic cancer after neoadjuvant chemotherapy. METHODS:A review of a prospectively maintained database for pancreatic resections was undertaken to identify patients undergoing resection for ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000371745

    authors: Addeo P,Rosso E,Fuchshuber P,Oussoultzoglou E,De Blasi V,Simone G,Belletier C,Dufour P,Bachellier P

    更新日期:2015-01-01 00:00:00

  • Accumulation of 111In-bleomycin in metastatic lesions from carcinoma of the uterine cervix and the ovary.

    abstract::Cases are presented in which 111In-bleomycin accumulated in Virchow's gland metastasis from squamous cell carcinoma of the uterine cervix, and in paratracheal lymphatic gland metastasis from embryonal carcinoma of the right ovary. Thus, this radiopharmaceutical was found to be of great use for assessment of metastatic...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226373

    authors: Kida T,Ikeda M

    更新日期:1986-01-01 00:00:00

  • Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species.

    abstract::Persistent infection with hepatitis C virus (HCV) is a major risk for the development of hepatocellular carcinoma (HCC). One of the characteristics of HCV infection is the unusual augmentation of oxidative stress, which is exacerbated by iron accumulation in the liver, as observed frequently in hepatitis C patients. U...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000333253

    authors: Fujinaga H,Tsutsumi T,Yotsuyanagi H,Moriya K,Koike K

    更新日期:2011-01-01 00:00:00

  • Expression of vascular endothelial growth factor D is associated with lymph node metastasis in human colorectal carcinoma.

    abstract:OBJECTIVE:Expression of vascular endothelial growth factor (VEGF)-D by tumors is associated with metastasis to lymph nodes in mice. However, there are few reports concerning the clinical significance of VEGF-D protein in human carcinoma. METHODS:After confirming production of VEGF-D by eight colorectal carcinoma cell ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000070301

    authors: Funaki H,Nishimura G,Harada S,Ninomiya I,Terada I,Fushida S,Tani T,Fujimura T,Kayahara M,Shimizu K,Ohta T,Miwa K

    更新日期:2003-01-01 00:00:00